Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s scientific evidence on the presence of opioid compounds in kratom, underscoring its potential for abuse Additional adverse events associated with kratom use identified February 6, 2018 Summary FDA releases adverse events and scientific analysis providing even stronger evidence of kratom compounds’ opioid properties. Statement Over … Continue reading Kratom: FDA Releases Latest Science on Adverse Events